Sydney Lupkin
speaker
1,064 appearances
108 recordings
3 series
first heard Dec 2024
last heard 4d ago
Sydney Lupkin’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 93 in all, peaking in Jul 2026 with 21.
Appearances
The trials are double blind, meaning that neither the patient nor the doctors know who got the drug and who got the placebo.
Also, what is this pill called, by the way?
Oh, it's called Orpaglipron, and it did work.
According to one study, patients who took Orpaglipron had 12% average weight loss at its highest dose over 72 weeks.
Cool.
And another study showed it was also effective at lowering patients' A1c, which is a measure of blood sugar.
Novo Nordisk may have a bit of an edge here.
In a study published in September in the New England Journal of Medicine, a 25 mg semaglutide pill led to a 16-17% reduction in weight on average over 64 weeks.
Some just aren't into the idea.
They're like, hey, the injections work for me.
Why would I switch?
But overall, the pill is another option, and that's big, especially when it comes to cost.
And that's on top of already high insurance premiums.
So even if you have insurance coverage, it might be really limited or still require a big out-of-pocket payment.
So we don't officially know what the sticker price for the pills is going to be yet.
Novo Nordisk has not said.
Eli Lilly has not said.
But generally, pills are easier to manufacture.
Therefore, they're cheaper to manufacture, which could result in a downstream lower price.
We also know that there have been deals with the Trump administration announced earlier this year to sell the pills to consumers not using their health insurance for $149 a month.
Showing 721–740 of 1,064 · page 37 of 54
← Previous
Next →